Physician profile
Celso T Ebeo
NPI 1104812734
$17,829.49
in general payments reported to CMS, 2019-2025
57 companies · $2,162 in 2025
The $2,162 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,829 · 2020: $1,579 · 2021: $1,787 · 2022: $1,828 · 2023: $2,599 · 2024: $6,044 · 2025: $2,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,298 · Education: $3,014 · Travel and Lodging: $1,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,297.58 |
| Education | $3,014.38 |
| Travel and Lodging | $1,493.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,711.50 | 2023-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,971.35 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,649.65 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $913.37 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $906.10 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $684.38 | 2019-2025 | Dupixent |
| Philips North America LLC | $679.01 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Electromed, INC. | $539.34 | 2019-2025 | Smartvest |
| Grifols USA, LLC | $521.06 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $470.70 | 2020-2025 | Acthar |
| Genzyme Corporation | $434.47 | 2019-2025 | |
| Insmed, INC. | $432.12 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $334.42 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $275.83 | 2019-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $257.44 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $250.54 | 2019-2021 | |
| Baxter Healthcare | $242.86 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Astellas Pharma US INC | $216.51 | 2020-2025 | Cresemba |
| Advanced Respiratory, INC | $165.99 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $150.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $143.36 | 2021-2025 | Glassia |
| Gilead Sciences, INC. | $139.53 | 2021-2024 | Veklury |
| Viatris Specialty LLC | $133.52 | 2025 | Yupelri |
| Jazz Pharmaceuticals INC. | $130.96 | 2019-2024 | |
| Harmony Biosciences LLC | $128.17 | 2022-2023 | Wakix |
| Genentech USA, INC. | $102.28 | 2019-2023 | Xolair |
| Pfizer INC. | $101.71 | 2019-2025 | |
| Amgen INC. | $97.86 | 2023-2025 | Tezspire, Tavneos |
| Inspire Medical Systems, INC. | $97.32 | 2023 | Inspire |
| Inogen, INC. | $85.36 | 2024-2025 | |
| Abbvie INC. | $80.23 | 2021-2024 | Avycaz |
| Verona Pharma, INC. | $67.24 | 2025 | Ohtuvayre |
| Shire North American Group INC | $63.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $62.31 | 2019-2021 | |
| Shionogi INC | $62.25 | 2023-2024 | Fetroja |
| Daiichi Sankyo INC. | $57.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.65 | 2022 | |
| Janssen Pharmaceuticals, INC | $40.17 | 2019-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $37.25 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $35.14 | 2023-2024 | Purified Cortrophin Gel |
| Paratek Pharmaceuticals, INC. | $28.99 | 2023-2024 | Nuzyra |
| Nabriva Therapeutics, Plc | $27.58 | 2021 | |
| Circassia INC. | $24.28 | 2019-2020 | |
| Pulmonx Corporation | $22.27 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| La Jolla Pharmaceutical Company | $21.65 | 2024 | Xacduro |
| Portola Pharmaceuticals, LLC | $20.38 | 2019 | |
| Vapotherm INC | $19.78 | 2019 | |
| Vifor Pharma, INC. | $19.42 | 2024 | Zemaira |
| Biogen, INC. | $19.34 | 2022 | |
| Lilly USA, LLC | $17.50 | 2025 | Zepbound |
| Resmed Corp | $15.41 | 2025 | |
| Caris Mpi, INC. | $14.24 | 2025 | Mi Cancer Seek |
| Ethicon INC. | $13.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.72 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.99 | 2022 | |
| Ambu INC. | $11.60 | 2020 | |
| Allergan, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celso Ebeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.